首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   562篇
  免费   68篇
  630篇
  2023年   5篇
  2021年   12篇
  2020年   9篇
  2019年   7篇
  2018年   13篇
  2017年   7篇
  2016年   16篇
  2015年   15篇
  2014年   27篇
  2013年   33篇
  2012年   28篇
  2011年   33篇
  2010年   22篇
  2009年   18篇
  2008年   26篇
  2007年   28篇
  2006年   24篇
  2005年   15篇
  2004年   20篇
  2003年   31篇
  2002年   21篇
  2001年   13篇
  2000年   20篇
  1999年   18篇
  1998年   6篇
  1996年   5篇
  1995年   4篇
  1994年   5篇
  1993年   4篇
  1992年   5篇
  1991年   12篇
  1990年   8篇
  1989年   6篇
  1988年   8篇
  1987年   6篇
  1986年   13篇
  1985年   4篇
  1984年   6篇
  1982年   4篇
  1981年   4篇
  1979年   6篇
  1978年   5篇
  1976年   5篇
  1975年   3篇
  1974年   5篇
  1973年   5篇
  1972年   3篇
  1968年   3篇
  1945年   3篇
  1942年   6篇
排序方式: 共有630条查询结果,搜索用时 0 毫秒
621.
We derive mathematically the output of Corey and Hudspeth's hair cell transducer function for the following cases: (1) the input is a single carrier whose output is modulated by the sum of two sinusoids; (2) the input is the sum of two carriers, each of which is amplitude-modulated by a single sinusoid. The theoretical results are similar to the results of an experiment in which field potentials were recorded from the human scalp while one ear was stimulated with auditory waveform (1) and with auditory waveform (2) of the cases above.  相似文献   
622.
DNA repair in human progeroid cells   总被引:4,自引:0,他引:4  
  相似文献   
623.
624.
625.
626.
627.
628.
629.
BackgroundA nonavalent human papillomavirus (HPV) vaccine has been licensed for use in women and men up to age 45 years in the United States. The cost-effectiveness of HPV vaccination for women and men aged 30 to 45 years in the context of cervical cancer screening practice was evaluated to inform national guidelines.Methods and findingsWe utilized 2 independent HPV microsimulation models to evaluate the cost-effectiveness of extending the upper age limit of HPV vaccination in women (from age 26 years) and men (from age 21 years) up to age 30, 35, 40, or 45 years. The models were empirically calibrated to reflect the burden of HPV and related cancers in the US population and used standardized inputs regarding historical and future vaccination uptake, vaccine efficacy, cervical cancer screening, and costs. Disease outcomes included cervical, anal, oropharyngeal, vulvar, vaginal, and penile cancers, as well as genital warts. Both models projected higher costs and greater health benefits as the upper age limit of HPV vaccination increased. Strategies of vaccinating females and males up to ages 30, 35, and 40 years were found to be less cost-effective than vaccinating up to age 45 years, which had an incremental cost-effectiveness ratio (ICER) greater than a commonly accepted upper threshold of $200,000 per quality-adjusted life year (QALY) gained. When including all HPV-related outcomes, the ICER for vaccinating up to age 45 years ranged from $315,700 to $440,600 per QALY gained. Assumptions regarding cervical screening compliance, vaccine costs, and the natural history of noncervical HPV-related cancers had major impacts on the cost-effectiveness of the vaccination strategies. Key limitations of the study were related to uncertainties in the data used to inform the models, including the timing of vaccine impact on noncervical cancers and vaccine efficacy at older ages.ConclusionsOur results from 2 independent models suggest that HPV vaccination for adult women and men aged 30 to 45 years is unlikely to represent good value for money in the US.

Jane Kim and co-workers estimate the potential cost-effectiveness of papillomavirus vaccination for adults aged 30-45 years in the United States.  相似文献   
630.
A tetrahedral zinc(II)-binding site introduced into a designed protein   总被引:14,自引:0,他引:14  
L Regan  N D Clarke 《Biochemistry》1990,29(49):10878-10883
The ultimate goal of protein engineering is to create novel proteins which will adopt predetermined structures, bind specified ligands, and catalyze new reactions. Here we describe the successful introduction of metal-binding activity into a model four helix bundle protein. The designed binding site is tetrahedral and is formed by two Cys and two His ligands on adjacent helices. We have introduced this site into the protein and characterized the binding activity. Using 65Zn(II), we have shown that the protein binds Zn(II), that the sulfhydryls are essential for binding, and that binding occurs to the protein monomer. The designed protein binds metals with high affinity: we estimate the dissociation constants as 2.5 X 10(-8) M for Zn(II) and 1.6 X 10(-5) M for Co(II). The characteristic absorption spectrum of the Co(II)-substituted protein fully supports the model of a tetrahedral binding site comprised of two Cys and two His ligands. Circular dichroism studies indicate that no significant changes in secondary structure occur between the metal-bound and metal-free forms of the protein. However, the metal-bound form is substantially stabilized toward denaturation by GuHCl compared to the metal-free form.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号